• Beauty Health Co SKIN reported a quarterly adjusted loss of 7 cents​​ per share for the quarter ended in December, lower than the same quarter last year, when the company reported EPS of 5 cents. The mean expectation of ten analysts for the quarter was for a loss of 7 cents per share. Wall Street expected results to range from -12 cents tozero cents per share.

• Revenue fell 1.3% to $96.80 million from a year ago; analysts expected $87.63 million.

• Beauty Health Co’s reported EPS for the quarter was a loss of 7 cents​.

• The company reported a quarterly loss of $9.4 million.

• Beauty Health Co shares had risen by 17.0% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 3.6% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is “hold” and the breakdown of recommendations is 3 “strong buy” or “buy,” 7 “hold” and 3 “sell” or “strong sell.”

• The average consensus recommendation for the personal products peer group is also “hold”

Wall Street’s median 12-month price target for Beauty Health Co is $2.50

This summary was machine generated from LSEG data March 12 at 09:49 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)